January 6, 2025 - 20:23

CHICAGO, Jan. 06, 2025 — Tidal Financial Group is excited to announce its acquisition of ZEGA Financial’s trading business, a move that significantly enhances its trading team and solidifies its leadership in the exchange-traded fund (ETF) market. This strategic acquisition marks a pivotal moment for Tidal, effectively doubling its trading personnel and bolstering its already robust trading capabilities.
By integrating ZEGA's renowned expertise in options trading, Tidal is poised to offer a comprehensive suite of trading services that will cater to a diverse range of clients. The acquisition not only enhances Tidal's operational capacity but also positions the firm as a formidable player in the financial sector, particularly in the rapidly evolving ETF landscape.
Tidal’s commitment to innovation and excellence in the ETF space is further reinforced by this acquisition, allowing the company to deliver enhanced value to its clients and maintain its competitive edge in the industry. The future looks promising as Tidal continues to expand its offerings and redefine the standards of trading excellence.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...